azacitidine has been researched along with Anaplastic Large-Cell Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilban, M; Egger, G; Hassler, MR; Klisaroska, A; Kollmann, K; Schiefer, AI; Sexl, V; Steiner, I | 1 |
Berg, E; Hummel, M; Joosten, M; Lenze, D; Leser, U; Seitz, V; Sommerfeld, A; Stein, H; Zimmermann, K | 1 |
1 review(s) available for azacitidine and Anaplastic Large-Cell Lymphoma
Article | Year |
---|---|
Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large-Cell, Anaplastic; Mice; Receptor Protein-Tyrosine Kinases; Transcriptome; Xenograft Model Antitumor Assays | 2012 |
1 other study(ies) available for azacitidine and Anaplastic Large-Cell Lymphoma
Article | Year |
---|---|
Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype.
Topics: Azacitidine; B-Lymphocytes; Cell Line, Tumor; Cluster Analysis; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Hydroxamic Acids; Inhibitor of Differentiation Protein 2; Lymphoma, Large-Cell, Anaplastic; Phenotype; Promoter Regions, Genetic; T-Lymphocytes; Transcription Factors | 2013 |